FBLA vs VRTX · rev $66.5M vs P/E 30, rev $12.00B
FB Bancorp, Inc. Common Stock (FBLA) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
FB Bancorp, Inc. Common Stock (FBLA) is a banks - regional company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported FBLA revenue for 2024-12-31 was $66.5M. Net income was -$6.2M. Revenue was down 3.8% from 2023-12-31 to 2024-12-31. FBLA currently screens at market cap $225.9M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
FBLA currently screens at market cap $225.9M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the FBLA and VRTX stock pages for the full models.
Not investment advice.